如何量化与比较手术试验中的伤害
本文为视角研究,以管与小梁切除术青光眼试验为范例,将共识来源的并发症严重程度分类系统应用于已发表数据,把每种并发症的严重等级乘以发生该并发症的患者数,估算每种干预的总伤害评分,并用图形工具展示组间差异。作者认为临床试验中的伤害数据分析需进一步关注,严重程度分类系统与总伤害评分可用于量化青光眼术后伤害。
要点
- 将并发症严重等级乘以发生该并发症的患者数,可估算每种干预的总伤害评分。
- 图形工具可用于展示试验组间并发症差异。
- 作者认为临床试验中的伤害数据分析需进一步关注。
核心结论
- 作者认为临床试验中的伤害数据分析需进一步关注,严重程度分类系统与总伤害评分可用于量化青光眼术后伤害,图形工具有助于解读并发症数据。
研究设计与样本
- 视角研究,以一项已发表的标志性青光眼试验(管与小梁切除术青光眼试验)为范例,将共识来源的并发症严重程度分类系统应用于其已发表数据,并进行伤害数据报告最佳实践的文献综述。
主要发现
- 将每种并发症的严重等级乘以发生该并发症的患者数,可估算每种干预的总伤害评分。
- 图形工具可用于展示试验组间并发症差异。
- 随机对照试验中事件数和样本量相对较小,使治疗伤害分析具有挑战性,但术后伤害的量化与图形化展示是可行的。
- 将研究问题重新定位为检测不良反应信号并使用贝叶斯分析可能有帮助。
临床怎么用
- 原文未据此给出推荐,作者在结论中提出严重程度分类系统与总伤害评分可用于量化青光眼术后伤害,图形工具有助于解读并发症数据。
局限性
- 作者指出随机对照试验中事件数和样本量相对较小,使治疗伤害分析具有挑战性。
- 作者认为临床试验中的伤害数据分析需进一步关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe methods that can be used to quantify and compare harm caused by surgical interventions in ophthalmology trials. DESIGN: Perspective study. METHODS: A published landmark glaucoma trial was used as an exemplar. A consensus-derived classification system of severity of complications was applied to published data of the Tube Versus Trabeculectomy glaucoma trial. The severity grade of each complication was multiplied to the number of patients who incurred that complication to estimate a total harm score for each intervention. Graphical tools were also used to display the differences in complications between trial arms. A review of literature on best practice for reporting harm data was also conducted. RESULTS: Analyzing treatment harm is challenging with the relatively small number of events and sample sizes used in randomized controlled trials. However, quantification and graphical representation of harm after surgery is possible. Reframing the research question to one for detecting signals of adverse reactions and use of Bayesian analyses can be useful. CONCLUSIONS: Analysis of harm data in clinical trials needs further attention. A severity classification system and a total harm score can be used to quantify harm after glaucoma surgery. Graphical tools can also help interpret complication data.
引用
- Protasio JN, King A, Pasquale LR, et al. How Can We Quantify and Compare Harm in Surgical Trials? Am J Ophthalmol. 2022. PMID: 35526589. doi:10.1016/j.ajo.2022.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。